A phase II study of cyclophosphamide, paclitaxel, cisplatin with G-SF for patients with newly diagnosed advanced stage ovarian cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Cyclophosphamide; Granulocyte colony-stimulating factors; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions; Therapeutic Use
- 05 Apr 2018 Biomarkers information updated
- 01 Jul 2010 Actual patient number (47) added as reported by ClinicalTrials.gov.
- 01 Jul 2010 Actual patient number (47) added as reported by ClinicalTrials.gov.